Physician profile
Thomas S Yang
NPI 1538106216
$5,029.84
in general payments reported to CMS, 2019-2025
26 companies · $754 in 2025
The $754 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,117 · 2020: $660 · 2021: $1,052 · 2022: $447 · 2023: $779 · 2024: $222 · 2025: $754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,755.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,382.41 | 2019-2024 | Senza |
| Globus Medical, INC. | $464.47 | 2025 | Senza, Vyrsa V1 |
| Medtronic, INC. | $393.24 | 2021-2023 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $316.24 | 2021 | |
| Pfizer INC. | $232.07 | 2020-2023 | |
| Abbott Laboratories | $188.23 | 2020-2023 | Proclaim |
| Nalu Medical, INC. | $156.73 | 2025 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $131.08 | 2023-2025 | Belbuca, Xtampza |
| Zyla Life Sciences, INC. | $126.53 | 2019-2020 | |
| Vertiflex, INC. | $120.17 | 2019 | |
| Foundation Fusion Solutions, LLC | $89.13 | 2020 | |
| Ibsa Pharma INC. | $55.56 | 2020-2021 | |
| Assertio Therapeutics, INC. | $53.27 | 2019-2020 | |
| Lilly USA, LLC | $39.52 | 2021 | |
| Mdd US Operations, LLC | $39.11 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $33.41 | 2025 | |
| Vertos Medical, INC. | $31.65 | 2023 | Mild Device Kit |
| Abbvie INC. | $27.00 | 2025 | |
| Daiichi Sankyo INC. | $21.96 | 2019 | |
| Impel Pharmaceuticals INC. | $21.16 | 2022 | |
| Medtronic USA, INC. | $21.09 | 2020 | |
| Biotronik Nro, INC. | $20.55 | 2025 | Prospera |
| Averitas Pharma INC. | $20.42 | 2024 | Qutenza |
| Painteq LLC | $19.15 | 2024 | Painteq |
| Arbor Pharmaceuticals, INC. | $12.92 | 2019 | |
| Amgen INC. | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.